MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

H Horn, M Ziepert, C Becher, TFE Barth… - Blood, The Journal …, 2013 - ashpublications.org
… the integration of MYC protein expression and the MYC translocation status into existing …
(or MYC rearrangement status) in concert with BCL2high and BCL6low status emerged as …

MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified

LX Yan, YH Liu, DL Luo, F Zhang, Y Cheng, XL Luo… - PLoS …, 2014 - journals.plos.org
… high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS had multiple adverse prognostic
factors including high LDH level, poor performance status… , high MYC/BCL2 DHS, high MYC/…

Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer

MD Planas-Silva, RD Bruggeman, RT Grenko… - … and molecular pathology, 2007 - Elsevier
… Clinical evidence suggest that c-Myc and Bcl-2 act in concert to promote lymph node … with
either c-Myc or Bcl-2 expression (Table 2). Only Bcl-2 correlated with ER status. In addition, we …

The incidence and treatment response of double expression of MYC and BCL2 in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis

J Hwang, CH Suh, KW Kim, HS Kim, AI Kim, JW Craig… - Cancers, 2021 - mdpi.com
… The pooled proportions of double expressor status as well as MYC and BCL2 protein
expression (independently) were computed using the inverse variance method for calculating …

MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?

C Thieblemont, J Briere - Blood, The Journal of the American …, 2013 - ashpublications.org
… , MYC in concert with BCL6 and BCL2 appear to have a role to play in refractory/relapsed
DLBCL. MYCMYC status in concert with BCL2 and BCL6 expression predicts outcome in …

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy

K Miura, H Takahashi, M Nakagawa, A Izu… - Leukemia & …, 2016 - Taylor & Francis
… As to the patient distribution according to the MYC/BCL2 status, the histological form of
DLBCL was more common in DEL, whereas the other backgrounds were generally balanced [ …

Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL

L Li, X Zhang, T Zhang, Z Song, G Hu, W Li, L Li… - … Myeloma and Leukemia, 2018 - Elsevier
BCL-2 + /MYC − expression showed a trend toward poorer survival than those with BCL-2
/MYC + expression, suggesting that BCL-2MYC expression in concert with BCL2 and BCL6 …

Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical …

AM Staiger, M Ziepert, H Horn, DW Scott… - Journal of clinical …, 2017 - ascopubs.org
… prognostic impact of MYC/BCL2 DE status in DLBCL. In … complex interplay between MYC/BCL2
status and COO, as … subgroups, whereas MYC/BCL2 DE status was highly prognostic of …

Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with …

M Schmidt-Hansen, S Berendse, T Marafioti… - Leukemia & …, 2017 - Taylor & Francis
Full article: Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic
information beyond the International Prognostic Index score in patients with diffuse large B-…

[HTML][HTML] Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma

B Xia, L Zhang, SQ Guo, XW Li, FL Qu… - World Journal of …, 2015 - ncbi.nlm.nih.gov
… protein and mRNA levels of MYC and BCL-2. We found that MYC + /BCL-2 + patients have
worse … The status of chemotherapy response was evaluated by Cheson’s standard criteria. …